Related Experiment Video
Updated: Jun 21, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
A novel association between polycystic ovary syndrome and Helicobacter pylori
Irfan Yavasoglu1, Mert Kucuk, Burak Cildag
1Division of Internal Medicine, Balmumcu Military Medical Center, Istanbul, Turkey. dr_yavas@yahoo.com
Background:
Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies. Chronic infections may increase the risk of infertility. Helicobacter pylori infection has been found to be associated with infertility, and PCOS is also one of the most common causes of infertility. To the best of our knowledge, the possible association between H. pylori seropositivity and PCOS has never been investigated.
Methods:
We performed a prospective study between a group of PCOS subjects and an age-matched group of controls. This prospective study included 35 women (mean age, 25 +/- 5 years) with PCOS, selected by using revised diagnostic criteria of European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine 2003, who were compared with their age-matched control group (50 women; mean age, 26 +/- 5 years). The 1-step H. pylori test device was used to detect IgG-type antibodies to H. pylori in serum, to aid in the diagnosis of H. pylori infection.
Results:
H. pylori seropositivity was found to be significantly higher in the PCOS group (PCOS 40%; control 22%; P = 0.007).
Conclusion:
We suggest a possible association between H. pylori seropositivity and PCOS. It is early to state that H. pylori is a new etiological factor for PCOS or the association of PCOS and H. pylori infection is coincidental with these data. Further studies evaluating more subjects are required.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
